Episode Summary
Executive Summary: The episode examines herpes simplex virus (HSV-1 and HSV-2) through biology, history, and stigma. It features Courtney Braem’s personal diagnosis and anti-stigma nonprofit work, explains HSV transmission, latency, symptoms, and treatment, traces the virus’s deep evolutionary history and the social panic of the 1980s, and closes with Dr. Ina Park on sex-positive care, language, and why better counseling—not fear—reduces harm.
Main Topics: Personal diagnosis and origin of SPFPP: Courtney Braem recounts her genital HSV-2 diagnosis, immediate fear and partner notification, and how her own experience led her to create Something Positive for Positive People as a peer-support and suicide-prevention resource. HSV biology and clinical course: The episode explains HSV transmission, incubation, lesions, latency in nerve ganglia, asymptomatic shedding, recurrence patterns, complications, and antiviral management. Evolutionary and historical origins: Hosts describe HSV-1 as an ancient human companion and HSV-2 as later acquired from cross-species transmission, then outline early historical references and treatment attempts. Rise of herpes stigma in the late 20th century: The discussion shows how herpes became a moral symbol of sexual wrongdoing in the 1970s–80s, amplified by media fearmongering and dehumanizing language. Screening, treatment, and vaccine gaps: The episode critiques weak diagnostic screening, explains why universal screening is not recommended, and notes that antiviral therapy helps but does not eradicate infection; vaccine development remains unsuccessful. Sex-positive counseling and language reform: Dr. Ina Park emphasizes harm reduction, early sex education, better provider communication, and shifting terminology toward 'HSV positive' to reduce shame.
Key Arguments: HSV is extremely common, often asymptomatic, and can be transmitted even without visible sores because shedding frequently occurs during asymptomatic periods. Herpes stigma can trigger serious mental health distress; Courtney frames SPFPP as a suicide-prevention and mental-health support resource as much as a herpes resource. The social meaning of herpes changed dramatically in the 1970s–80s, when it became a moralized symbol of sexual liberation rather than simply a common viral infection. Condoms and avoiding sex during outbreaks reduce risk but do not fully prevent transmission because HSV sheds from mucosal surfaces and can be asymptomatic. Current screening is limited mainly because HSV tests are poor, with high false-positive rates and limited confirmatory testing access. Provider discomfort with sex contributes to patient shame; systematic, nonjudgmental sexual-history collection is preferable when clinicians lack comfort or training. Public health messaging should avoid scare tactics and instead normalize STI risk, promote harm reduction, and encourage care-seeking. Language matters: terms like 'unclean' or 'having herpes' reinforce stigma; 'HSV positive' is more accurate and less dehumanizing.
Data Points: Global HSV-1 prevalence under age 50: 3.7 billion people (67%) - WHO estimate cited in the prevalence section Genital HSV-1 among HSV-1 cases: 120–190 million people - WHO estimate for people with genital rather than oral HSV-1 Global HSV-2 prevalence ages 15–49: 491 million people (13%) - WHO estimate cited by hosts Typical incubation period: ~4 days - Time from infection to symptoms, with range noted as 2–12 days and sometimes up to a month Shedding during asymptomatic periods: Up to 80% of shedding time - Hosts explain that viral shedding often occurs without visible lesions Shedding frequency in some studies: About 25% of days - Described for HSV-positive people regardless of symptoms Primary symptomatic recurrence risk: 90% - People with symptomatic primary infection will have at least one recurrence within the first year Genital herpes lesion duration in primary infection: 8–11+ days - Typical healing time for initial outbreak HSV encephalitis incidence: 2–4 cases per 1 million worldwide per year - Rare but severe complication HSV encephalitis share of viral encephalitis: 50–75% of identified cases in the U.S. - HSV is the most common identified cause of viral encephalitis Untreated HSV encephalitis mortality: ~70% - High fatality without treatment HSV-1 evolutionary origin with humans: 6–7 million years ago - Estimated split with last common ancestor with other primates HSV-2 cross-species acquisition: 1.4–3 million years ago - Estimated later acquisition from chimpanzee herpes virus U.S. HSV-2 prevalence change: 13.6% to 15.7% - Reported increase from 1970 to 1985 Increase in doctor visits for genital herpes: 10-fold - Same 1970–1985 period, reflecting rising awareness and fear
Pivotal Quotes: "My purpose is to just give people the resources to navigate the stigma." — Courtney Braem: Explaining the mission of Something Positive for Positive People "HSV is assuredly wilier than we are clever." — Episode narration citing a paper: Concluding that vaccine development remains difficult "I think changing our language would certainly help." — Dr. Ina Park: On replacing shame-based STI terminology with more accurate, less stigmatizing language
Implications: Listeners are urged to see HSV as common, manageable, and not morally defining. Better sex education, less shame, improved clinical communication, and mental-health support can reduce harm even before a vaccine or better screening arrives.